Visualizing the Next Best Thing to Human
Meet InSphero imaging experts and our head of 3D plate technology and organ-on-a-chip solutions to learn more about high content imaging applications for our 3D InSight™ platforms for drug discovery and safety testing.
- Preview the imaging capabilities of our new Akura™ 384 plates and other microtissue delivery formats, which are specifically engineered for 3D InSight™ microtissue platforms for metabolic disease and oncology
- Learn how to optimize advanced high content imaging and screening technology for 3D cell culture applications
- Hear how InSphero and Novo Nordisk are applying HCI using an islet-peripheral blood mononuclear cell (PBMC) co-culture platform
- Meet with our director of imaging strategy to discuss potential partnerships to develop imaging applications using 3D InSight™ microtissues
Judi Wardwell, our SBI2 conference team leader and director of imaging strategy, will be at booth 15 and in the poster hall on Thursday. Judi is also on the board of SBI2 and will be working behind the scenes of this meeting to make sure everything goes smoothly. To ensure you have time to meet with her, we highly recommend scheduling a time in advance for a one-on-one meeting.
This stunning image of a 3D InSight™ gastric tumor model (GFP-tagged NCI_N87 in co-culture with RFP-tagged NIH3T3 mouse fibroblasts) was visualized using the PerkinElmer, Inc. Opera Phenix™ High Content Screening System. InSphero's new Akura™ 384 plate design enhances high content imaging quality with a continuous, flat-bottom 25 µm semipermeable membrane, and eliminates fluorescent crosstalk between wells with a black-walled body. Image credit: PE Biological Applications Group, Hamburg, Germany.
Presenting Author: Olivier Frey, PhD, Head of Technology and Platforms, InSphero
Title: 3D Cell Culture for Advanced High-content Imaging and Screening
Poster presentations: Thursday, September 19, 10:30 AM – Noon
Poster Number: 14
Presenting Author: Judi Wardwell, Senior Application Scientist, InSphero
Title: A Novel in vitro Human Islet Platform for Studying Type 1 Diabetes
September 17-19, 2019
Joseph B. Martin Conference Center,
Harvard Medical School, Boston, MA
View the SBI2 Program
- InSphero Booth: 15